CIAM
PALI icon

Caitong International Asset Management’s Palisade Bio PALI Stock Holding History

Caitong International Asset Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,177
Closed -$21.3K – 3347
2026
Q1 		$21.3K Sell
12,177
-22,327
-65% -$40.6K ﹤0.01% 981
2025
Q4 		$81.1K Buy
+34,504
New +$66.3K 0.02% 516

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Caitong International Asset Management's PALI Position: Q2 2026 in Review

Caitong International Asset Management sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 12,177 shares — an estimated $21.3K sold.

Caitong International Asset Management first reported a position in PALI in Q4 2025 and held it in 2 quarters. The position peaked at $81.1K in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Caitong International Asset Management reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 12,177 Palisade Bio shares in Q2 2026, an estimated $21.3K.
  • Caitong International Asset Management first reported a position in Palisade Bio in Q4 2025 and held it in 2 quarters.
  • Caitong International Asset Management's Palisade Bio position peaked at $81.1K in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.